Regeneron Pharmaceuticals (REGN) Stock Chart & Stock Price History $681.58 -11.65 (-1.68%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Regeneron Pharmaceuticals Stock Price Performance 5 Day Performance-3.11%1 Month Performance-2.89%3 Month Performance-31.20%6 Month Performance-35.92%Year-To-Date Performance-4.32%1 Year Performance-26.98% Receive REGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address REGN Stock Chart for Monday, January, 20, 2025 REGN Chart by TradingView Regeneron Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/17/2025$693.23$681.58-1.68%$707.48$680.891.11 million shs$74.90 billion01/16/2025$703.43$693.23-1.45%$706.54$691.33853,934 shs$76.18 billion01/15/2025$690.87$703.43+1.82%$712.60$698.20880,396 shs$77.30 billion01/14/2025$716.90$690.87-3.63%$715.98$686.00790,015 shs$75.92 billion01/13/2025$696.88$716.90+2.87%$717.37$666.251.41 million shs$78.78 billion01/10/2025$733.59$696.88-5.00%$724.73$691.001.12 million shs$76.58 billion01/09/2025$733.59$733.59$743.28$725.60758,759 shs$80.61 billion01/08/2025$730.30$733.59+0.45%$743.28$725.60758,759 shs$80.61 billion01/07/2025$716.26$730.30+1.96%$734.44$716.34802,499 shs$80.25 billion01/06/2025$718.15$716.26-0.26%$733.69$713.75820,268 shs$78.71 billion Get the Latest News and Ratings for REGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 01/03/2025$715.19$718.15+0.41%$722.00$714.76557,944 shs$78.92 billion01/02/2025$712.33$715.19+0.40%$726.81$711.92479,036 shs$78.59 billion01/01/2025$712.33$712.33$713.00$703.39473,514 shs$78.28 billion12/31/2024$702.59$712.33+1.39%$713.00$703.39473,514 shs$78.28 billion12/30/2024$712.40$702.59-1.38%$708.97$700.42537,234 shs$77.21 billion12/27/2024$716.68$712.40-0.60%$718.99$709.09795,499 shs$78.29 billion12/26/2024$714.47$716.68+0.31%$718.49$709.08619,236 shs$78.76 billion12/25/2024$714.47$714.47$720.00$706.15382,145 shs$78.51 billion12/24/2024$715.13$714.47-0.09%$720.00$706.15382,145 shs$78.51 billion12/23/2024$701.85$715.13+1.89%$718.19$706.16866,457 shs$78.59 billion12/20/2024$708.25$701.85-0.90%$717.61$700.831.89 million shs$77.13 billion12/19/2024$714.62$708.25-0.89%$714.05$693.00990,833 shs$77.83 billion Related Companies Amgen Stock Price Chart Gilead Sciences Stock Price Chart Vertex Pharmaceuticals Stock Price Chart Alnylam Pharmaceuticals Stock Price Chart Biogen Stock Price Chart United Therapeutics Stock Price Chart Neurocrine Biosciences Stock Price Chart Incyte Stock Price Chart BioMarin Pharmaceutical Stock Price Chart Exact Sciences Stock Price Chart Receive REGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:REGN) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regeneron Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
